Amarin Corporation plc - Depositary Receipt (Common Stock)
US ˙ NasdaqCM ˙ US0231112063

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Joseph S Zakrzewski. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Joseph S Zakrzewski har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US: / AN2 THERAPEUTICS Director 145.538
US:CYT / Cyteir Therapeutics, Inc. Director 227.439
US:SGMO / Sangamo Therapeutics, Inc. Director 25.000
US:AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) Director 196.547
US:XLRN / Acceleron Pharma Inc Director 0
US:PODD / Insulet Corporation Director 3.587
US:LPDX / Liposcience Inc Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Joseph S Zakrzewski. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2021-12-15 AMRN Zakrzewski Joseph S 2.000 3,1550 100 63,1000 6.310 48 3.73 -5.937 -94,09
2021-12-14 AMRN Zakrzewski Joseph S 10.000 3,2689 500 65,3780 32.689
2013-11-18 AMRN Zakrzewski Joseph S 50.777 1,5400 2.539 30,8000 78.197

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) Insider Trades
Insidersalg AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2012-03-23 AMRN Zakrzewski Joseph S 160.000 11,5910 8.000 231,8200 1.854.560 343 7.55 -1.794.160 -96,74

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) Insider Trades
Insiderkøb SGMO / Sangamo Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock). Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2020-03-17 SGMO Zakrzewski Joseph S 5.000 4,9900 5.000 4,9900 24.950 281 18.18 65.950 264,33
2020-03-13 SGMO Zakrzewski Joseph S 5.000 5,6700 5.000 5,6700 28.350
2020-03-12 SGMO Zakrzewski Joseph S 15.000 6,3100 15.000 6,3100 94.650

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SGMO / Sangamo Therapeutics, Inc. Insider Trades
Insidersalg SGMO / Sangamo Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock). Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SGMO / Sangamo Therapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Joseph S Zakrzewski som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-04-11 2025-04-10 4 ANTX AN2 Therapeutics, Inc.
Common Stock
A - Award 10.523 145.538 7,79
2024-12-23 2024-12-19 4 ANTX AN2 Therapeutics, Inc.
Common Stock
A - Award 9.816 135.015 7,84
2024-11-27 2024-11-27 4 ANTX AN2 Therapeutics, Inc.
Common Stock
P - Purchase 2.000 125.199 1,62 1,40 2.800 175.279
2024-11-20 2024-11-19 4 ANTX AN2 Therapeutics, Inc.
Common Stock
P - Purchase 5.000 123.199 4,23 1,01 5.050 124.431
2024-11-20 2024-11-18 4 ANTX AN2 Therapeutics, Inc.
Common Stock
P - Purchase 20.000 118.199 20,37 1,00 19.996 118.175
2024-02-08 2024-02-06 4 CYT Cyteir Therapeutics, Inc.
Common Stock
M - Exercise 14.150 227.439 6,63 1,69 23.914 384.372
2024-01-19 2024-01-18 4 ANTX AN2 Therapeutics, Inc.
Common Stock
S - Sale -100.000 405.880 -19,77 19,11 -1.911.410 7.758.031
2022-12-08 2022-12-07 4 CYT Cyteir Therapeutics, Inc.
Common Stock
P - Purchase 21.202 154.618 15,89 1,30 27.563 201.003
2022-05-16 2022-05-12 4 CYT Cyteir Therapeutics, Inc.
Common Stock
P - Purchase 743 133.416 0,56 1,61 1.196 214.800
2022-05-16 2022-05-12 4 ANTX AN2 Therapeutics, Inc.
Stock Option (right to buy)
A - Award 10.362 10.362
2022-05-12 2022-05-11 4 CYT Cyteir Therapeutics, Inc.
Common Stock
P - Purchase 1.000 132.673 0,76 1,70 1.700 225.544
2022-05-12 2022-05-10 4 CYT Cyteir Therapeutics, Inc.
Common Stock
P - Purchase 49.406 131.673 60,06 1,89 93.377 248.862
2022-03-31 2022-03-29 4 ANTX AN2 Therapeutics, Inc.
Series A Convertible Preferred Stock
C - Conversion -98.199 0 -100,00
2022-03-31 2022-03-29 4 ANTX AN2 Therapeutics, Inc.
Common Stock
C - Conversion 98.199 98.199
2022-03-24 3 ANTX AN2 Therapeutics, Inc.
Common Stock
505.880
2022-03-01 2022-02-25 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
A - Award 25.000 25.000
2022-03-01 2022-02-25 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
A - Award 12.500 60.700 25,93
2022-02-24 2022-02-22 4 CYT Cyteir Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 14.150 14.150
2021-12-28 2021-12-28 4 CYT Cyteir Therapeutics, Inc.
Common Stock
P - Purchase 601 82.267 0,74 9,85 5.920 810.330
2021-12-28 2021-12-27 4 CYT Cyteir Therapeutics, Inc.
Common Stock
P - Purchase 99 81.666 0,12 10,18 1.008 831.360
2021-12-28 2021-12-27 4 CYT Cyteir Therapeutics, Inc.
Common Stock
P - Purchase 200 81.567 0,25 9,97 1.994 813.223
2021-12-28 2021-12-23 4 CYT Cyteir Therapeutics, Inc.
Common Stock
P - Purchase 200 81.367 0,25 9,87 1.974 803.092
2021-12-21 2021-12-17 4 CYT Cyteir Therapeutics, Inc.
Common Stock
P - Purchase 200 81.167 0,25 9,88 1.976 801.930
2021-12-16 2021-12-15 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
P - Purchase 2.000 196.547 1,03 3,16 6.310 620.106
2021-12-16 2021-12-14 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
P - Purchase 10.000 194.547 5,42 3,27 32.689 635.955
2021-12-15 2021-12-15 4 CYT Cyteir Therapeutics, Inc.
Common Stock
P - Purchase 1.700 80.967 2,14 11,12 18.904 900.353
2021-12-15 2021-12-15 4 CYT Cyteir Therapeutics, Inc.
Common Stock
P - Purchase 2.000 79.267 2,59 10,47 20.940 829.925
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -3.222 0 -100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -8.185 0 -100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -7.500 0 -100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -7.500 0 -100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -10.000 0 -100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -10.000 0 -100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer -7.500 0 -100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Common Stock
U - Other -34.499 0 -100,00
2021-06-24 2021-06-22 4 CYT Cyteir Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -200.000 0 -100,00
2021-06-24 2021-06-22 4 CYT Cyteir Therapeutics, Inc.
Common Stock
C - Conversion 58.671 58.671
2021-06-17 3 CYT Cyteir Therapeutics, Inc.
Common Stock
77.267
2021-06-17 3 CYT Cyteir Therapeutics, Inc.
Common Stock
149.051
2021-06-16 2021-06-14 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
A - Award 36.000 36.000
2021-06-16 2021-06-14 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
A - Award 45.953 45.953
2021-04-05 2021-04-05 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -10.000 0 -100,00
2021-04-05 2021-04-05 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1.100 34.499 -3,09 142,27 -156.497 4.908.173
2021-04-05 2021-04-05 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -2.152 35.599 -5,70 141,28 -304.035 5.029.427
2021-04-05 2021-04-05 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -6.748 37.751 -15,16 140,31 -946.812 5.296.843
2021-04-05 2021-04-05 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 10.000 44.499 28,99 24,11 241.100 1.072.871
2021-04-02 2021-04-01 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X -10.000 10.000 -50,00
2021-04-02 2021-04-01 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1.600 34.499 -4,43 135,67 -217.072 4.680.479
2021-04-02 2021-04-01 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -1.700 36.099 -4,50 135,22 -229.874 4.881.307
2021-04-02 2021-04-01 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -6.596 37.799 -14,86 134,27 -885.645 5.075.272
2021-04-02 2021-04-01 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X -104 44.395 -0,23 132,61 -13.791 5.887.221
2021-04-02 2021-04-01 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 10.000 44.499 28,99 24,11 241.100 1.072.871
2021-03-01 2021-02-25 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
A - Award 16.400 16.400
2021-03-01 2021-02-25 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
A - Award 8.200 48.200 20,50
2021-02-02 2021-01-29 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 3.222 3.222
2021-02-02 2021-01-29 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1.622 34.499 4,93
2020-10-22 2020-10-21 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise -100.000 0 -100,00
2020-10-22 2020-10-21 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise 100.000 184.547 118,28 3,40 340.000 627.460
2020-07-15 2020-07-13 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
A - Award 27.191 27.191
2020-07-15 2020-07-13 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
A - Award 34.805 34.805
2020-06-03 2020-05-18 4/A SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
A - Award 20.000 20.000
2020-06-03 2020-05-18 4/A SGMO SANGAMO THERAPEUTICS, INC
Common Stock
A - Award 10.000 40.000 33,33
2020-05-20 2020-05-18 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
A - Award 15.000 15.000
2020-05-20 2020-05-18 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
A - Award 2.500 32.500 8,33
2020-03-19 2020-03-17 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
P - Purchase 5.000 30.000 20,00 4,99 24.950 149.700
2020-03-13 2020-03-13 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
P - Purchase 5.000 25.000 25,00 5,67 28.350 141.750
2020-03-13 2020-03-12 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
P - Purchase 15.000 20.000 300,00 6,31 94.650 126.200
2020-01-24 2020-01-22 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 8.185 8.185
2020-01-24 2020-01-22 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1.377 32.877 4,37
2020-01-09 2020-01-07 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise -18.750 0 -100,00
2020-01-09 2020-01-07 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 18.750 31.500 147,06 3,88 72.750 122.220
2020-01-03 2020-01-03 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise -300.000 100.000 -75,00
2020-01-03 2020-01-03 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -300.000 84.547 -78,01 20,94 -6.282.870 1.770.659
2020-01-03 2020-01-03 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise X 300.000 384.547 354,83 3,40 1.020.000 1.307.460
2019-12-18 2019-12-16 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise 100.000 138.542 259,46
2019-12-18 2019-12-16 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -100.000 84.547 -54,19 25,83 -2.583.380 2.184.170
2019-12-18 2019-12-16 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise X 100.000 184.547 118,28 9,00 900.000 1.660.923
2019-07-05 2019-07-05 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise -100.000 238.542 -29,54
2019-07-05 2019-07-05 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -100.000 84.547 -54,19 23,82 -2.381.580 2.013.554
2019-07-05 2019-07-05 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise X 100.000 184.547 118,28 9,00 900.000 1.660.923
2019-06-20 2019-06-18 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise -100.000 400.000 -20,00
2019-06-20 2019-06-18 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -100.000 84.547 -54,19 19,02 -1.902.090 1.608.160
2019-06-20 2019-06-18 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise X 100.000 184.547 118,28 3,40 340.000 627.460
2019-06-17 2019-06-14 4 XLRN ACCELERON PHARMA INC
Common Stock
P - Purchase 5.000 12.750 64,52 38,05 190.250 485.138
2019-06-12 2019-06-10 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
A - Award 15.000 15.000
2019-06-12 2019-06-10 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
A - Award 2.500 5.000 100,00
2019-05-21 2019-05-20 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
A - Award 7.428 7.428
2019-05-21 2019-05-20 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
A - Award 9.658 9.658
2019-02-22 2019-02-22 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise -36.875 0 -100,00
2019-02-22 2019-02-22 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise -143.750 0 -100,00
2019-02-22 2019-02-22 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -180.625 84.547 -68,12 19,90 -3.594.438 1.682.485
2019-02-22 2019-02-22 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise X 36.875 265.172 16,15 8,10 298.688 2.147.893
2019-02-22 2019-02-22 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise X 143.750 228.297 170,02 8,86 1.273.625 2.022.711
2019-01-29 2019-01-25 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 7.500 7.500
2019-01-29 2019-01-25 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1.250 7.750 19,23
2019-01-11 2019-01-10 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise -200.000 500.000 -28,57
2019-01-11 2019-01-10 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -100.000 84.547 -54,19 17,96 -1.796.080 1.518.532
2019-01-11 2019-01-10 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -100.000 184.547 -35,14 16,00 -1.600.310 2.953.324
2019-01-11 2019-01-10 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise X 200.000 284.547 236,55 3,40 680.000 967.460
2019-01-02 2019-01-02 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise -35.000 0 -100,00
2019-01-02 2019-01-02 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise -350.000 700.000 -33,33
2019-01-02 2019-01-02 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -385.000 84.547 -81,99 13,03 -5.015.703 1.101.461
2019-01-02 2019-01-02 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise X 35.000 469.547 8,05 1,35 47.250 633.888
2019-01-02 2019-01-02 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise X 350.000 434.547 413,97 3,40 1.190.000 1.477.460
2019-01-02 2018-12-28 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -141.500 84.547 -62,60 13,19 -1.866.668 1.115.344
2018-10-02 2018-05-14 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
A - Award 31.153 31.153
2018-10-02 2018-05-14 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
A - Award 46.973 46.973
2018-09-26 2018-09-24 4 AMRN AMARIN CORP PLC\UK
Stock Option (Right to Buy)
M - Exercise -500.000 1.050.000 -32,26
2018-09-26 2018-09-24 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -65.800 226.047 -22,55 12,18 -801.319 2.752.823
2018-09-26 2018-09-24 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -26.949 291.847 -8,45 11,23 -302.678 3.277.880
2018-09-26 2018-09-24 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -407.251 318.796 -56,09 10,30 -4.195.337 3.284.109
2018-09-26 2018-09-24 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise X 500.000 726.047 221,19 3,40 1.700.000 2.468.560
2018-06-12 2018-06-11 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
A - Award 15.000 15.000
2018-06-12 2018-06-11 4 SGMO SANGAMO THERAPEUTICS, INC
Common Stock
A - Award 2.500 2.500
2018-03-05 2018-03-01 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 7.500 7.500
2018-03-05 2018-03-01 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1.250 6.500 23,81
2017-06-29 2017-06-27 4 SGMO SANGAMO THERAPEUTICS, INC
Stock Option (Right to Buy)
A - Award 30.000 30.000
2017-05-18 2017-05-17 4 PODD INSULET CORP
Stock Option (Right to Buy)
A - Award 3.587 3.587
2017-05-18 2017-05-17 4 PODD INSULET CORP
Common Stock
A - Award 2.709 30.558 9,73
2017-05-17 2017-05-15 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
A - Award 14.706 14.706
2017-05-17 2017-05-15 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
A - Award 21.146 21.146
2017-03-14 2017-03-02 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 7.500 7.500
2017-03-14 2017-03-02 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1.250 5.250 31,25
2017-03-03 2017-03-02 4 PODD INSULET CORP
Stock Option (Right to Buy)
M - Exercise -4.000 0 -100,00
2017-03-03 2017-03-02 4 PODD INSULET CORP
Stock Option (Right to Buy)
M - Exercise -4.000 0 -100,00
2017-03-03 2017-03-02 4 PODD INSULET CORP
Stock Option (Right to Buy)
M - Exercise -4.000 0 -100,00
2017-03-03 2017-03-02 4 PODD INSULET CORP
Stock Option (Right to Buy)
M - Exercise -18.480 0 -100,00
2017-03-03 2017-03-02 4 PODD INSULET CORP
Stock Option (Right to Buy)
M - Exercise -9.520 0 -100,00
2017-03-03 2017-03-02 4 PODD INSULET CORP
Common Stock
S - Sale -22.279 27.849 -44,44 46,99 -1.046.906 1.308.644
2017-03-03 2017-03-02 4 PODD INSULET CORP
Common Stock
S - Sale -13.721 50.128 -21,49 46,31 -635.465 2.321.593
2017-03-03 2017-03-02 4 PODD INSULET CORP
Common Stock
S - Sale -4.000 63.849 -5,90 48,03 -192.124 3.066.731
2017-03-03 2017-03-02 4 PODD INSULET CORP
Common Stock
M - Exercise 4.000 67.849 6,26 17,75 71.000 1.204.320
2017-03-03 2017-03-02 4 PODD INSULET CORP
Common Stock
M - Exercise 4.000 63.849 6,68 20,90 83.600 1.334.444
2017-03-03 2017-03-02 4 PODD INSULET CORP
Common Stock
M - Exercise 4.000 59.849 7,16 14,48 57.920 866.614
2017-03-03 2017-03-02 4 PODD INSULET CORP
Common Stock
M - Exercise 18.480 55.849 49,45 7,06 130.469 394.294
2017-03-03 2017-03-02 4 PODD INSULET CORP
Common Stock
M - Exercise 9.520 37.369 34,18 18,75 178.500 700.669
2017-01-03 2016-12-30 4 XLRN ACCELERON PHARMA INC
Common Stock
P - Purchase 4.000 4.000 25,50 102.000 102.000
2016-07-13 2016-07-11 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
A - Award 20.548 20.548
2016-07-13 2016-07-11 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
A - Award 28.847 28.847
2016-05-13 2016-05-11 4 PODD INSULET CORP
Stock Option (Right to Buy)
A - Award 5.235 5.235
2016-05-13 2016-05-11 4 PODD INSULET CORP
Common Stock
A - Award 3.810 27.849 15,85
2016-03-07 2016-03-03 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 10.000 10.000
2015-07-08 2015-07-06 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
A - Award 18.000 18.000
2015-07-08 2015-07-06 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
A - Award 40.500 40.500
2015-07-08 2015-07-06 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
A - Award 23.144 23.144
2015-07-08 2015-07-06 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
A - Award 17.358 17.358
2015-05-18 2015-05-13 4 PODD INSULET CORP
Stock Option (Right to Buy)
A - Award 5.525 5.525
2015-05-18 2015-05-13 4 PODD INSULET CORP
Common Stock
A - Award 4.039 24.039 20,20
2015-04-08 2015-01-08 4/A XLRN ACCELERON PHARMA INC
Option to purchase Common Stock
A - Award 10.000 10.000
2015-01-09 2015-01-08 4 XLRN ACCELERON PHARMA INC
Option to purchase Common Stock
A - Award 10.000 10.000
2014-11-24 2014-11-20 4 LPDX LIPOSCIENCE INC
Common Stock
D - Sale to Issuer -25.372 0 -100,00 5,25 -133.203
2014-06-13 2014-06-02 4 PODD INSULET CORP
Stock Option (Right to Buy)
A - Award 4.000 4.000
2014-06-13 2014-06-02 4 PODD INSULET CORP
Common Stock
A - Award 4.000 20.000 25,00
2014-06-13 2014-06-11 4 LPDX LIPOSCIENCE INC
Common Stock
A - Award 8.955 25.372 54,55
2014-06-13 2014-06-11 4 LPDX LIPOSCIENCE INC
Common Stock
A - Award 16.417 16.417
2014-03-13 2014-03-11 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
A - Award 24.000 24.000
2014-03-13 2014-03-11 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
A - Award 28.500 28.500
2013-12-09 2013-12-05 4 XLRN ACCELERON PHARMA INC
Option to purchase Common Stock
A - Award 20.000 20.000
2013-11-18 2013-11-18 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
P - Purchase 50.777 226.047 28,97 1,54 78.197 348.112
2013-07-26 2013-07-26 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
M - Exercise -33.333 0 -100,00
2013-07-26 2013-07-26 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise 33.333 175.270 23,48
2013-06-25 2013-06-25 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
M - Exercise -10.000 35.000 -22,22
2013-06-25 2013-06-25 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise 10.000 141.937 7,58 1,35 13.500 191.615
2013-06-21 2013-06-21 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
M - Exercise -10.000 45.000 -18,18
2013-06-21 2013-06-21 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise 10.000 131.937 8,20 1,35 13.500 178.115
2013-06-05 2013-06-03 4 PODD INSULET CORP
Stock Option (Right to Buy)
A - Award 4.000 4.000
2013-06-05 2013-06-03 4 PODD INSULET CORP
Common Stock
A - Award 4.000 16.000 33,33
2013-04-25 2013-04-25 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
M - Exercise -10.000 55.000 -15,38
2013-04-25 2013-04-25 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise 10.000 121.937 8,93 1,35 13.500 164.615
2013-01-02 2013-01-02 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
A - Award 147.500 147.500
2012-10-03 2012-10-01 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
M - Exercise -150.000 65.000 -69,77
2012-10-03 2012-10-01 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -150.000 111.937 -57,27 12,56 -1.884.315 1.406.164
2012-10-03 2012-10-01 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise 150.000 261.937 134,00 1,35 202.500 353.615
2012-07-30 2012-07-27 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
M - Exercise -150.000 215.000 -41,10
2012-07-30 2012-07-27 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -78.054 111.937 -41,08 14,07 -1.098.220 1.574.954
2012-07-30 2012-07-27 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -71.946 189.991 -27,47 14,58 -1.048.973 2.770.069
2012-07-30 2012-07-27 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise 150.000 261.937 134,00 1,35 202.500 353.615
2012-07-30 2012-07-26 4 AMRN AMARIN CORP PLC\UK
Restricted Stock Units
A - Award 33.333 33.333
2012-07-30 2012-07-26 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
A - Award 33.333 111.937 42,41
2012-06-05 2012-06-01 4 PODD INSULET CORP
Stock Option (Right to Buy)
A - Award 4.000 4.000
2012-06-05 2012-06-01 4 PODD INSULET CORP
Common Stock
A - Award 4.000 12.000 50,00
2012-05-31 2012-05-29 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
M - Exercise -150.000 365.000 -29,13
2012-05-31 2012-05-29 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale X -150.000 78.604 -65,62 11,97 -1.795.215 940.741
2012-05-31 2012-05-29 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise 150.000 228.604 190,83 1,35 202.500 308.615
2012-03-27 2012-03-23 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
M - Exercise -160.000 515.000 -23,70
2012-03-27 2012-03-23 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
S - Sale -160.000 78.604 -67,06 11,59 -1.854.560 911.099
2012-03-27 2012-03-23 4 AMRN AMARIN CORP PLC\UK
Ordinary Shares
M - Exercise 160.000 238.604 203,55 1,35 216.000 322.115
2012-02-21 2012-02-17 4 PODD INSULET CORP
Common Stock
S - Sale -3.000 8.000 -27,27 20,20 -60.593 161.582
2012-02-21 2012-02-16 4 PODD INSULET CORP
Common Stock
S - Sale -2.000 11.000 -15,38 20,67 -41.342 227.382
2012-02-03 2012-02-01 4 AMRN AMARIN CORP PLC\UK
Stock Option (right to buy)
A - Award 300.000 300.000
2010-12-30 3 AMRN AMARIN CORP PLC\UK
Ordinary Shares
43.604
2010-12-30 3 AMRN AMARIN CORP PLC\UK
Ordinary Shares
10.000
2008-05-12 3 PODD INSULET CORP
No Securities are beneficially owned
0
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)